STAT

In STAT Madness, CRISPR tools to treat brain disorders capture Editors’ Pick

The 2019 #STATMadness Editors' Pick is the @WhiteheadInst's research on using a new form of #CRISPR to develop treatments for brain disorders such as fragile X.

The identities of the inventors of the hammer are lost to history, but we suspect that once they had their first working model, they quickly started bashing stuff. In 2016, biologist Shawn Liu felt the same way.

He and colleagues at the Whitehead Institute in Cambridge, Mass., had just invented a form of CRISPR-Cas9 that, unlike the original genome editing tool, leaves DNA’s “letters” alone but adds or removes genetic silencers turning gene expression off or on. (A few other teams came up with the same idea for “epigenetic editing” almost simultaneously.)

Liu, a postdoctoral fellow in

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks